Bayer's cell and gene therapy ambitions have quickly taken flight as the German conglomerate locks up new partners and pumps cash into promising up-and-comers. Now, the company is looking to beef up ...

$250 million (USD) plant will help produce transformational cell and gene therapies on a global scale Creating readiness for first production runs of potential commercial launches, including ...

As biopharmaceutical companies progress in their research of new cell and gene therapies, each one encounters the same choice: outsource the manufacturing of these complex medicines or build that ...